Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleDose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJinseok Kim